FDA Introduces AI Platform to Accelerate Scientific Reviews and Modernize Operations
TL;DR Summary
The FDA launched Elsa, a secure AI platform that significantly reduces task times and aims to modernize agency workflows, marking the beginning of several AI initiatives to enhance internal operations and better serve the public.
- US Food and Drug Administration Launches AI Platform to 'Modernize' Agency Decrypt
- FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People fda.gov
- The FDA rolls out its own AI to speed up clinical reviews and scientific evaluations Engadget
- FDA launches agency-wide AI tool ‘Elsa’ ahead of schedule Regulatory Affairs Professionals Society | RAPS
- US FDA launches AI tool to reduce time taken for scientific reviews Reuters
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 3 min read
Condensed
92%
441 → 35 words
Want the full story? Read the original article
Read on Decrypt